A certified, dedicated, self-motivated, experienced, and passionate in cultivating and maintaining relationships with KOLs internationally, nationally, and regionally to increase scientific and clinical knowledge of products and clinical pipeline. Therapeutic areas of expertise include oncology, nephrology. Detailed and results orientated with strong business acumen, interpersonal and problem-solving skills.
Key Achievements
Key Achievements
Ø Successfully managed and encouraged non-recruiting sites of a Cardiology (HCM) trial to identify new patients resulting in the achievement of recruitment objectives within timelines. - Special congratulation and recognition by the study team.
Key Achievements
Ø Rescue of seven sites of a clinical research that were poorly monitored by a contractor Senior CRA
Ø Successfully bringing all sites to an inspection readiness status within 9 months
Ø Gaining significant recognition from the Project Manager
Ø Successfully retaining the sponsor for further studies
Verbal Communication
undefinedProfessional experience
Excellent communication skills across a variety of internal and external audiences including listening skills and probing skills.
Strong interpersonal skills, presentation skills, and analytical ability strongly desired
Strong collaboration and presentation skills, problem-solving skills, and creative thinking. Lifelong learning mind-set
Proven track record of strong analytical capability, prioritizing skills, and problem-solving ability.
Excellent communication skills (i.e., verbal, written, presentations) and demonstrated group speaking experience.
Strong communication skills, written and verbal, active listening skills and an open, inclusive mindset.
Exemplary interpersonal communication skills, both oral and written, and strong presentation skills
Commercial skills
Competitive intelligence
Ø Systematic observation of our competitors in our fields of business to create the competitive landscape – emerging science, studies/approvals in progress, competitive moves, market introductions or withdrawals.
Ø Evaluate the impact of competitive information to share internally and externally as post-meeting deliverables.
Ø Promotion and sales skills
Clinical Research and Medical affairs Operation:
Ø Over 15 years of overall experience in pharmaceutical industry (Sponsor/CRO/CMO).
Ø 12 years rare diseases trial experience
Ø Strong experience in clinical study design, preparation of research proposals, data analysis and manuscripts preparation.
Ø Skills and experience in relationship management.
Pharmacology:
Ø GMP assurance,
Ø SOP development,
Ø IMP Management and documentation.
Therapeutic area & phase
Infectious Disease, international.
Ø Phase III, Malaria
Ø Phase II, Meningitis
Ø Phase IIb, Meningitis
Ø Phase II, HCV
Cardiovascular, international.
Ø Phase III, Hyper Cardiomyopathy
Oncology, international.
Ø Phase II, treatment of vomiting and nausea during chemotherapy
Ø Phase III, treatment of Follicular lymphoma (1L)
Ø R Phase III, treatment of T-cell lymphoma (r/r 2L)
Ø Phase II, Treatment of metastatic squamous cell carcinoma of the head and neck (1L)
Ø Phase II single arm metastatic Cutaneous Squamous Cell Carcinoma (1L)
Ø Phase III stud) metastatic non-squamous NSCLC
Ø Phase III, Renal Cell Carcinoma Post Nephrectomy (1L)
Ø Phase III, Metastatic Hormone-naïve Prostate Cancer (1L)
Ø Phase III, Localized Prostate Cancer, and High-risk Features of Relapse (1L)
Ø Phase II, Metastatic Renal Cell Carcinoma (1L)
Ø Phase II relapse refractory diffuse B-cells lymphoma (r/r DLBCL)
Ø Phase III treatment naïve diffuse B-cells lymphoma (1L DLBCL)
Ø Phase III Treatment of Myelofibrosis in naïve JAKi patients (1L)
Ø Phase II Treatment of Myelodysplastic Syndrome (MDS)
Immunology, international
Ø Phase IV, HIV (Immune reconstitution)
Ø Phase IIb, Primary immunodeficiency (PIDs) – (Rare disease)
Ø Phase III, Dermatomyositis – (orphan disease)
Ø Phase Ib/II Membranous Nephropathy – (Rare disease)
Ø Phase I IgA Nephropathy – (Rare disease)
Metabolic disorder, international
Ø Phase III, Growth Failure – (Rare disease)
Transplantation, international
Ø Phase II, treatment of HCV/HBV in liver transplantation – (Rare disease)
Ø Phase II, treatment of Indolent Systemic Mastocytosis – (Rare disease)
Ø Phase II AMR in Kidney (Rare disease)
CNS, international
Ø Phase II, treatment of Dravet Syndrome – (Rare disease)
Mini MBA - Project Management, International Business Institute
Mini MBA - Project Management, International Business Institute
Marketing Essentials , International Business Institute
Time Management, International Business Institute
Human Resource Management, International Business Institute
[Area of certification], [Company Name] - [Timeframe]